Showing results (321-330 of 374) with videos related to
Sort By:
Pageof 38
Journal of Oncology Practice|October 6, 2017
Where Are the Opportunities for Reducing Health Care Spending Within Alternative Payment Models?Gabrielle B Rocque, Courtney P Williams, Kelly M Kenzik, et al.Journal of Lower Genital Tract Disease|April 4, 2020
Challenges Associated With Cervical Cancer Screening and Management in Obese Women: A Provider PerspectiveMegan A Clarke, L Stewart Massad, Michelle J Khan, et al.Gynecologic Oncology|July 23, 2025
The use of transrectal ultrasound to improve gynecologic interstitial applicator implantationKatelyn Ragland, Joel Pogue, Eric Simiele, et al.Gynecologic Oncology|February 27, 2007
A multi-institutional review of outcomes of endometrial stromal sarcomaCharles A Leath, Warner K Huh, Johnny Hyde, et al.Journal of Virology|March 29, 2013
Phylogenetic considerations in designing a broadly protective multimeric L2 vaccineSubhashini Jagu, Kihyuck Kwak, John T Schiller, et al.Journal of Lower Genital Tract Disease|September 28, 2017
ASCCP Colposcopy Standards: Colposcopy Quality Improvement Recommendations for the United StatesEdward J Mayeaux, Akiva P Novetsky, David Chelmow, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 17, 2002
A Phase I study of combined modality (90)Yttrium-CC49 intraperitoneal radioimmunotherapy for ovarian cancerRonald D Alvarez, Warner K Huh, M B Khazaeli, et al.Journal of Lower Genital Tract Disease|December 20, 2023
2019 ASCCP Risk-Based Management Consensus Guidelines: Updates Through 2023Rebecca B Perkins, Richard S Guido, Philip E Castle, et al.Gynecologic Oncology|December 17, 2003
Uterine papillary serous carcinoma: comparisons of outcomes in surgical Stage I patients with and without adjuvant therapyWarner K Huh, Matthew Powell, Charles A Leath, et al.Gynecologic Oncology Reports|January 15, 2020
Phase II evaluation of copanlisib, a selective inhibitor of Pi3kca, in patients with persistent or recurrent endometrial carcinoma harboring PIK3CA hotspot mutations: An NRG Oncology study (NRG-GY008)Alessandro D Santin, Virginia Filiaci, Stefania Bellone, et al.Pageof 38